Holen Sie sich die Stockscreener-App
57.61
3.15%
-1.8164
Schlusskurs vom Vortag:
$59.43
Offen:
$58.86
24-Stunden-Volumen:
250.67K
Relative Volume:
0.39
Marktkapitalisierung:
$2.43B
Einnahmen:
$17.39M
Nettoeinkommen (Verlust:
$-135.89M
KGV:
-12.42
EPS:
-4.64
Netto-Cashflow:
$-123.00M
1W Leistung:
+4.16%
1M Leistung:
-1.74%
6M Leistung:
+17.66%
1J Leistung:
+78.26%
1-Tages-Spanne:
$56.96
$59.78
1-Wochen-Bereich:
$54.16
$59.78
52-Wochen-Spanne:
$31.73
$59.78
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Firmenname
Tarsus Pharmaceuticals Inc
Sektor
Branche
Telefon
(949) 409-9820
Adresse
15440 LAGUNA CANYON ROAD, IRVINE
Vergleichen Sie TARS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
57.60 | 2.51B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.64 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.96 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.86 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
773.12 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.13 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-20 | Eingeleitet | Goldman | Neutral |
| 2023-07-18 | Eingeleitet | William Blair | Outperform |
| 2023-05-18 | Eingeleitet | Guggenheim | Buy |
| 2022-08-01 | Eingeleitet | Barclays | Overweight |
| 2021-12-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-23 | Eingeleitet | Oppenheimer | Outperform |
| 2020-11-10 | Eingeleitet | BofA Securities | Buy |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-11-10 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Tarsus Pharmaceuticals Hits Day High with Strong 7.29% Intraday Surge - Markets Mojo
Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight - GlobeNewswire Inc.
How Tarsus Pharmaceuticals Inc. stock trades before earnings2025 Investor Takeaways & Verified Momentum Stock Alerts - newser.com
Using Bollinger Bands to evaluate Tarsus Pharmaceuticals Inc.Watch List & Fast Gaining Stock Strategy Reports - newser.com
Tarsus Pharmaceuticals stock hits 52-week high at 59.76 USD By Investing.com - Investing.com Nigeria
Will Tarsus Pharmaceuticals Inc. benefit from macro trends2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Tarsus Pharmaceuticals stock hits 52-week high at 59.76 USD - Investing.com India
How Tarsus Pharmaceuticals Inc. stock reacts to inflationary pressuresMarket Rally & Risk Managed Investment Strategies - newser.com
Is Tarsus Pharmaceuticals Inc a good long term investmentTrendline Breakouts & Watch Expert Picks Before They Rally - earlytimes.in
Tarsus Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Why Tarsus Pharmaceuticals Inc. stock attracts high net worth investorsNew Guidance & Verified Momentum Watchlists - newser.com
Is Tarsus Pharmaceuticals Inc. forming a bottoming baseMarket Performance Recap & Community Consensus Stock Picks - newser.com
What drives Tarsus Pharmaceuticals Inc stock priceDividend Reinvestment Plans & Subscribe for Free Weekly Winners - earlytimes.in
Assessing Tarsus Pharmaceuticals (TARS) Valuation Following Fresh Institutional Investment and Analyst Upgrades - Sahm
Azamian, Tarsus Pharmaceuticals CEO, sells $332k in stock By Investing.com - Investing.com Nigeria
Azamian, Tarsus Pharmaceuticals CEO, sells $332k in stock - Investing.com India
Bobak Azamian Sells 6,000 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Tarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay Off (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
5,600 Shares in Tarsus Pharmaceuticals, Inc. $TARS Purchased by Strs Ohio - MarketBeat
Assenagon Asset Management S.A. Sells 127,718 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Aug Ideas: What is the long term forecast for Tarsus Pharmaceuticals Inc stockJuly 2025 Rallies & Daily Volume Surge Signals - خودرو بانک
Bond Watch: Why is Tarsus Pharmaceuticals Inc stock going downJuly 2025 Levels & Consistent Growth Stock Picks - خودرو بانک
Tarsus Pharmaceuticals gains amid takeover speculation - MSN
Hedge Fund Bets: Is Tarsus Pharmaceuticals Inc. stock forming a triangle pattern2025 AllTime Highs & Risk Controlled Stock Pick Alerts - خودرو بانک
Published on: 2025-09-20 01:31:03 - خودرو بانک
What is the long term forecast for Tarsus Pharmaceuticals Inc stockMarket Activity Recap & Safe Entry Momentum Tips - خودرو بانک
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Woodline Partners LP - MarketBeat
Can you recover from losses in Tarsus Pharmaceuticals Inc.July 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Aug Volume: Is Tarsus Pharmaceuticals Inc exposed to currency risksJuly 2025 Action & Fast Gaining Stock Reports - خودرو بانک
Using data tools to time your Tarsus Pharmaceuticals Inc. exitPortfolio Value Summary & High Yield Stock Recommendations - newser.com
Rhumbline Advisers Raises Position in Tarsus Pharmaceuticals, Inc. $TARS - Defense World
Tarsus Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Investment Report: Why is Xos Inc. stock going down2025 Technical Patterns & Daily Volume Surge Trade Alerts - خودرو بانک
Tarsus Pharmaceuticals seesaws amid report Alcon interest has cooled - MSN
Quarterly Recap: What is the long term forecast for Tarsus Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Safe Capital Growth Plans - خودرو بانک
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 4.1% on Insider Selling - MarketBeat
IPO Launch: What is Tarsus Pharmaceuticals Incs P E ratio telling us2025 Key Highlights & Daily Market Momentum Tracking - خودرو بانک
Growth Value: Does Tarsus Pharmaceuticals Inc have declining or rising EPS2025 Support & Resistance & AI Enhanced Execution Alerts - khodrobank.com
Sectors Review: Will Tarsus Pharmaceuticals Inc benefit from rising consumer demandMarket Trend Summary & Real-Time Volume Spike Alerts - خودرو بانک
Market Outlook: Will Tarsus Pharmaceuticals Inc benefit from green energy policiesJuly 2025 Intraday Action & High Conviction Buy Zone Alerts - خودرو بانک
Market Moves: Will Tarsus Pharmaceuticals Inc benefit from green energy policiesJuly 2025 Momentum & Consistent Return Investment Signals - خودرو بانک
Regression analysis insights on Tarsus Pharmaceuticals Inc. performanceJuly 2025 Price Swings & Reliable Price Breakout Signals - newser.com
Aug Patterns: Does Tarsus Pharmaceuticals Inc have declining or rising EPSQuarterly Profit Report & Weekly Stock Breakout Alerts - خودرو بانک
Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Director Sells 27,116 Shares of Stock - MarketBeat
Advanced analytics toolkit walkthrough for Tarsus Pharmaceuticals Inc.Market Activity Summary & Smart Allocation Stock Tips - newser.com
Surprises Report: Can VirnetX Holding Corporation generate free cash flowGDP Growth & Growth Focused Entry Reports - خودرو بانک
Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):